We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHLO
876
DELISTED
Shiloh Industries Inc
SHLO
| $229K | ﹤0.01% |
41,675
-2,500
| -6% | -$15K |
|
|
ADVM
877
DELISTED
Adverum Biotechnologies
ADVM
| $228K | ﹤0.01% |
4,360
-5,573
| -56% | -$225K |
|
878
Philip Morris
PM
$304B
| $227K | ﹤0.01% |
2,570
-148,522
| -98% | -$12M |
|
879
Fortress Biotech
FBIO
$108M
| $224K | ﹤0.01% |
8,393
-11,673
| -58% | -$306K |
|
880
Zevra Therapeutics
ZVRA
$572M
| $221K | ﹤0.01% |
8,258
+4,536
| +122% | +$167K |
|
881
Hamilton Beach Brands
HBB
$301M
| $219K | ﹤0.01% |
+10,225
| New | +$249K |
|
882
Skywest
SKYW
$4.34B
| $219K | ﹤0.01% |
+4,030
| New | +$207K |
|
|
MAXR
883
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $219K | ﹤0.01% |
+54,400
| New | +$320K |
|
884
Ardelyx
ARDX
$1.27B
| $218K | ﹤0.01% |
77,999
-21,615
| -22% | -$56.2K |
|
885
Tenable Holdings
TENB
$3.65B
| $216K | ﹤0.01% |
+6,810
| New | +$193K |
|
|
PMBC
886
DELISTED
Pacific Mercantile Bancorp
PMBC
| $216K | ﹤0.01% |
28,388
+600
| +2% | +$4.8K |
|
887
Spok Holdings
SPOK
$227M
| $215K | ﹤0.01% |
15,784
+900
| +6% | +$12.5K |
|
888
Arch Capital
ACGL
$36.4B
| $214K | ﹤0.01% |
+6,610
| New | +$201K |
|
889
Lee Enterprises
LEE
$173M
| $213K | ﹤0.01% |
6,444
-1,447
| -18% | -$41.2K |
|
|
LTC
890
LTC Properties
LTC
$2.14B
| $213K | ﹤0.01% |
+4,660
| New | +$209K |
|
891
Paychex
PAYX
$41.5B
| $213K | ﹤0.01% |
+2,660
| New | +$196K |
|
892
Unitil
UTL
$1B
| $210K | ﹤0.01% |
3,870
-148
| -4% | -$7.73K |
|
893
Home Bancorp
HBCP
$554M
| $208K | ﹤0.01% |
6,256
+230
| +4% | +$8.16K |
|
|
ARC
894
DELISTED
ARC Document Solutions, Inc.
ARC
| $208K | ﹤0.01% |
93,090
-217,275
| -70% | -$530K |
|
895
Perdoceo Education
PRDO
$1.99B
| $207K | ﹤0.01% |
12,500
| – | – |
|
896
Seagate
STX
$182B
| $205K | ﹤0.01% |
4,290
-1,100
| -20% | -$48.8K |
|
|
SHYF
897
DELISTED
The Shyft Group
SHYF
| $203K | ﹤0.01% |
+23,000
| New | +$196K |
|
|
RNWK
898
DELISTED
RealNetworks Inc
RNWK
| $203K | ﹤0.01% |
65,220
| – | – |
|
|
PGRE
899
DELISTED
Paramount Group
PGRE
| $201K | ﹤0.01% |
14,200
-502,909
| -97% | -$7.09M |
|
900
United Airlines
UAL
$38.7B
| $201K | ﹤0.01% |
2,520
-360
| -13% | -$30.4K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.